logo
Select company
Select metric
$ -121.2MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
6
Sector
15
Industry
22
History
47
$ 7.81Close
$ 5.48 - $ 16.44 52-Week Range
Ticker Information

Ticker

WVE

Company Name

WAVE LIFE SCIENCES LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

WAVE LIFE SCIENCES LTD - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

WVE - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 8.67M$ -129.87M$ -121.2M
3/31/2025$ 8.65M$ -112.33M$ -103.68M
12/31/2024$ 8.66M$ -97.01M$ -88.34M
9/30/2024$ 8.69M$ -142.52M$ -133.83M
6/30/2024$ 8.79M$ -74.16M$ -65.37M
3/31/2024$ 8.95M$ -62.34M$ -53.4M
12/31/2023$ 9.21M$ -58.19M$ -48.98M
9/30/2023$ 9.52M$ -84.96M$ -75.44M
6/30/2023$ 9.86M$ -130.54M$ -120.69M
3/31/2023$ 10.04M$ -150.73M$ -140.69M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • WAVE LIFE SCIENCES LTD's latest trailing twelve months (TTM) EBITDA stands at $ -167.99M.
  • Over the past 5 years, WAVE LIFE SCIENCES LTD's average EBITDA has been $ -113.12M.
  • The median EBITDA for WAVE LIFE SCIENCES LTD during this period was $ -116.65M
  • WAVE LIFE SCIENCES LTD reached its highest EBITDA over the past 5 years at $ -48.98M.
  • The lowest EBITDA recorded by WAVE LIFE SCIENCES LTD in the same timeframe $ -167.99M

WAVE LIFE SCIENCES LTD's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
URGN : UROGEN PHARMA LTD $ -134.34MSPRY : ARS PHARMACEUTICALS INC $ -47.12MNRIX : NURIX THERAPEUTICS INC $ -225.49MSNDX : SYNDAX PHARMACEUTICALS INC $ -313.35MNTLA : INTELLIA THERAPEUTICS INC $ -470.05MGYRE : GYRE THERAPEUTICS INC $ 9.86MZYME : ZYMEWORKS INC $ -54.55MNAGE : NIAGEN BIOSCIENCE INC $ 19.78MCRMD : CORMEDIX INC $ 52.25MABCL : ABCELLERA BIOLOGICS INC $ -132.93M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for WAVE LIFE SCIENCES LTD is calculated as follows: EBIT [ $ -177.89M ] + DepAmor [ $ 9.9M ]
(=) EBITDA [ $ -167.99M ]

WVE - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -167.99M

Minimum

Sep 30, 2020

$ -48.98M

Maximum

Dec 31, 2023

$ -113.12M

Average

$ -116.65M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M